AMLODIPINE vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AMLODIPINE vs OSIMERTINIB: Safety Overview
| Metric | AMLODIPINE | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 64,924 | 27,750 |
| Deaths Reported | 10,161 | 12,456 |
| Death Rate | 15.7% | 44.9% |
| Hospitalizations | 26,787 | 5,277 |
| Average Patient Age | 62.8 yrs | 68.2 yrs |
| % Female Patients | 57.0% | 66.0% |
| FDA Approval Date | Apr 12, 2011 | Nov 13, 2015 |
| Manufacturer | Teva Pharmaceuticals USA, Inc. | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |